Vitamin D status and ill health

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 4, 2014, Pages

  Macdonald, Helen M ^a   Wood, Adrian D ^a   Fraser, William D ^b   Simpson, William G ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; APOLIPOPROTEIN B100; PLACEBO; VITAMIN D;

GERIATRIC CARE; GERIATRIC PATIENT; HEALTH STATUS; HUMAN; LETTER; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEASONAL VARIATION; SUN EXPOSURE; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; COMPLICATION;

HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84897396966     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(14)70047-6     Document Type: Letter

References (5)

1. Autier P, Boniol M, Pizot C, Mullie P Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014, 2:76-89.
2. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006, 354:669-683. for the Women's Health Initiative Investigators.
3. Bolland MJ, Grey A, Gamble GD, Reid IR Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr 2011, 94:1144-1149.
4. Prentice RL, Pettinger MB, Jackson RD, et al. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int 2013, 24:567-580.
5. Wood AD, Secombes KR, Thies F, et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 2012, 97:3557-3568.